Twisting Fate
Pamela Munster, MD, is program leader of Developmental Therapeutics at UCSF’s Helen Diller Family Comprehensive Cancer Center. She shares a breast cancer story here – her own.
University of California San Francisco
Give to UCSFPamela Munster, MD, is program leader of Developmental Therapeutics at UCSF’s Helen Diller Family Comprehensive Cancer Center. She shares a breast cancer story here – her own.
UCSF is one of the first pharmacy schools in the nation to offer its students genetic testing for drug response. It’s just one way they're learning about the potential of precision medicine.
UCSF’s Yuet Wai Kan, an internationally recognized leader in the field of human genetics, will be honored at the Personalized Medicine World Conference, PMWC 2014, to be held in January 2014 in Silicon Valley.
A team led by UCSF scientists has identified the disruption of a single type of cell – in a particular brain region and at a particular time in brain development – as a significant factor in the emergence of autism.
The fall 2013 UCSF Magazine, which features the promise of precision medicine, is now available online.
Precision Medicine Pillar No. 6: Digital Health. The Center for Digital Health Innovation shepherds the development of digital health innovations created at UCSF and validates the effectiveness of devices from both inside and outside the institution.
Precision Medicine Pillar No. 5: Omics Medicine. Molecular biologist Nevan Krogan's work is not only illuminating how genes and proteins function, it's also shedding light on the underlying biology of disease for each person.
Precision Medicine Pillar No. 4: Computational Health Sciences. Computationally intensive approaches are used to analyze and cross-analyze large but discrete collections of data, such as patient health histories and genetic makeup.
Precision Medicine Pillar No. 3: Clinical Discovery. Researchers are taking vast amounts of patient data, often collected through first-ever clinical studies, and putting it into tools like MS Bioscreen that have a direct impact on patient care.
Precision Medicine Pillar No. 2: Basic Discovery. The long path to developing potent new treatments often starts with an observation in the lab that then leads to a question about a fundamental life process.
Today, with a host of tools garnered from precision medicine, patients can benefit from precise and effective therapies for some of the world's most daunting illnesses. <em>UCSF Magazine</em> explores the promise of precision medicine.
Precision Medicine Pillar No. 1: Knowledge Network. With an increased ability to harvest information automatically and more powerfully, scientists can find the connections among discoveries that would otherwise go unrecognized.
With inexpensive genetics kits flooding the market, both consumers — and their doctors — still lack basic information about what to do, if anything, with what they learn about their own genomes.
UCSF faculty members will discuss their cutting-edge approaches to researching and delivering health care on at Dreamforce 2013’s “Unusual Thinkers” track.
Researchers at the UCSF-affiliated Gladstone Institutes have discovered how the activation of specific stretches of DNA control the development of uniquely human characteristics.
David Baltimore, PhD, will present the 2013 Gladstone Distinguished Lecture on Wednesday, Nov. 20. The lecture, titled, “The Role of MicroRNAs in Immune Functions,” will begin at 4 p.m. in Gladstone’s Robert Mahley Auditorium.
UCSF's Pierre Theodore is the first surgeon to use the tech device, Google Glass, as a surgical tool to make a patient's CT and X-ray images available to him for quick reference while in the operating room.
A UCSF graduate program in complex biology led by Joseph DeRisi, PhD, is being lauded for its creativity with a $100,000 gift.
A UCSF-led team of scientists has discovered that a gene mutation found in some bladder cancers is indicative of low-risk tumors that are unlikely to recur or progress after surgery.
UCSF researchers received six of 78 awards announced this week by the National Institutes of Health for innovative, high-risk, high-reward research.
In her annual State of the University address, Chancellor Susan Desmond-Hellmann highlighted UCSF's investments in its research, education and patient care to meet the challenges ahead.
A new link between meal times and daily changes in the immune system has been identified by UCSF researchers, and has led them to question assumptions about the roles of specific immune cells in infection and allergy.
Scientists from UCSF have identified a new way to manipulate the immune system that may keep it from attacking the body’s own molecules in autoimmune diseases such as type 1 diabetes, rheumatoid arthritis and multiple sclerosis.
UCSF will receive $4.5 million for a pilot project to assess whether large-scale gene sequencing can and should become a routine part of newborn testing.